US Digestive Health Executive and Leadership Team

Scott Bennett, the Chief Executive Officer at US Digestive Health, directs the overarching strategic vision and operational expansion of the gastroenterology network. Bennett manages the integration of AI-enabled screening technologies across all clinical sites to ensure superior diagnostic accuracy. By overseeing the scaling of the practice, the Chief Executive Officer maintains high standards for patient-centered care throughout the Pennsylvania and Delaware markets. This leadership role involves coordinating with the board to secure long-term growth and operational efficiency. Scott Bennett drives the implementation of fast-track colonoscopy services, ensuring rapid access for patients requiring urgent digestive health interventions. Through rigorous oversight of administrative workflows, the Chief Executive Officer optimizes resource allocation to support the mission of early colorectal cancer detection. Bennett fosters a culture of excellence, ensuring the organization remains at the forefront of regional digestive health services while consistently meeting performance benchmarks.

Bruce Gonyea, the Chief Executive Officer & Co-Founder at US Digestive Health, architects the foundational business model and long-term market positioning of the organization. Gonyea focuses on the development of the practice infrastructure, ensuring the network maintains a competitive edge in the gastroenterology sector. By overseeing the expansion of telehealth options, the Chief Executive Officer & Co-Founder enhances patient accessibility across the entire regional footprint. This leadership role involves cultivating partnerships with GI specialists to maintain a high-quality clinical workforce. Bruce Gonyea drives the strategic initiatives that prioritize patient-centered care, ensuring that every location adheres to the core mission of digestive health excellence. Through the continuous evaluation of market trends, the Chief Executive Officer & Co-Founder identifies opportunities for service diversification. Gonyea secures the organizational stability necessary for sustained growth, ensuring that the practice remains a leader in providing cutting-edge care to a wide array of patients.

Yamaira Alicea, the Chief Financial Officer at US Digestive Health, manages the fiscal health and capital allocation strategies for the entire gastroenterology network. Alicea oversees the budgeting processes, ensuring that investments in state-of-the-art technology and AI-enabled screening tools align with the company's growth objectives. By directing financial planning and analysis, the Chief Financial Officer supports the expansion of clinical services across Pennsylvania and Delaware. This leadership role involves monitoring revenue cycles and optimizing operational costs to maintain the financial viability of the practice. Yamaira Alicea drives the development of financial models that facilitate the integration of new locations into the existing network. Through rigorous oversight of fiscal performance, the Chief Financial Officer ensures that resources remain available for the continuous improvement of patient care. Alicea provides the financial insights necessary for the executive team to make informed decisions regarding the future of the organization and its commitment to digestive health excellence.

Dale Whitebloom, the Chief Medical Officer at US Digestive Health, directs the clinical standards and medical protocols across the entire gastroenterology practice. Whitebloom oversees the recruitment and professional development of GI specialists, ensuring that every patient receives personalized treatment plans. By implementing advanced procedures such as colonoscopy, the Chief Medical Officer maintains the organization's reputation for cutting-edge care. This leadership role involves collaborating with the executive team to integrate AI-enabled screening into daily clinical practice. Dale Whitebloom drives the focus on early detection and prevention of colorectal cancer, ensuring that medical outcomes remain the top priority. Through the continuous monitoring of clinical quality metrics, the Chief Medical Officer ensures compliance with the highest standards of digestive health care. Whitebloom fosters a collaborative environment among medical staff, ensuring that the patient-centered approach remains consistent across all regional locations, ultimately enhancing the overall health outcomes for the patient population.